baeddel state-affiliate

[Text ID: THE WORLD WILL ALWAYS NEED MORE TRANSSEXUALS. THERE IS ROOM ENOUGH FOR EVERYONE. THAT INCLUDES YOU! /End ID]

TIME SENSITIVE.  my name is nathaniel. i’m a 24-year old trans man who recently moved in with my friend to escape a toxic / transphobic home environment.  in my family culture, transphobia runs deep, and it became impossible to live there while transitioning. originally i was sticking around in hopes to save money for a car. rent is due in two weeks, and i lost my job back in 2021, so i’m scrambling to figure out what to do. if i could get $300, it would help me pay my half of the rent, while i get on my feet and find work.  

please help if you can. or if not, just share. <3  finna repost this until we collectively scrape this together.

$0/300

Diana Davies, Donna Gottschalk holds poster “I am your worst fear I am your best fantasy” at Christopher Street Gay Liberation Day parade, 1970.

insulin has been mass produced (from animal extracts) since -1923-. slow acting insulin has existed since the ‘50s, and ‘human’ genetically engineered insulin (derived from E. coli bacteria) has existed since 1982.

insulin treatment for diabetes is not some new or ‘unproven’ treatment. according to beyondtype1, “Humalog rapid-acting insulin came on to the market with a list price of $21 a vial in 1997.” adjusting for inflation, a vial these days should cost about $34 at most. instead, it costs over $300. there is NO reason for it to be steadily gaining in price to the point that diabetics are unable to afford their lifesaving medication, other than the sheer inhuman greed of pharmaceutical manufacturers.

“ We’re a team of biohackers with a variety of backgrounds, and skills, and relationships to insulin and diabetes from many cities and countries around the world, including Oakland, California; Baltimore, Maryland; Paraiba, Brazil; Dakar, Senegal; Yaounde, Cameroon; and Puerto Rico. We’re working to develop the first practical, small-scale, community-centered model for insulin production to make insulin accessible to all. We envision a world in which communities in need have local sources of safe, affordable, high-quality insulin, and where people living with diabetes and their communities can own and govern the organizations that produce the medicine they depend on to survive. 

What We Do

We are creating an open-source (freely available) model for insulin production that centers on sustainable, small-scale manufacturing and open-source alternatives to production. We are developing protocols to produce short-acting (lispro) and long-acting (glargine) insulin, working on developing open-hardware equivalents to traditional production equipment, are researching sustainable regulation pathways to bring our insulin to the public, and are building capacities for local, small-scale manufacturing.

How Do I Participate?

Our work would not be possible without the support of volunteers, interns, and community advisors. We welcome people of all backgrounds from all over the world to bring their enthusiasm, time, connections, and experiences, both in life and in work. Our volunteers promote us on social media, build equipment, run experiments, write reports and blog posts, facilitate meetings, connect with other organizations and groups, meet with experts in the field, run virtual events, and contribute in designing tools, resources, and methods of all sorts.

Potential Partners

We welcome collaboration with other groups that share our mission―community labs, academic institutions, patient advocacy groups, and NGOs.

Donate

Your donation will help us get closer to our goal. With a healthy financial situation, we can pay for lab supplies, acquire lab equipment, recruit scientists, and pay for consultation fees for regulation and manufacturing experts.”